Find out now if you qualify. Time is limited to file a claim. You may be entitled to compensation. Fill out the form below to see if you qualify.


Free Claim Review

By clicking the “Submit” button below, I hereby grant my express written consent and authorize Tort Group LLC, and its affiliates and law firm partners, to contact me about their services at the phone number and email address provided above/below. I consent to receive telemarketing calls and text messages using an automatic telephone dialing system or prerecorded voice. I understand that the express written consent I provide here is not required in order to purchase any good or service. I also acknowledge and agree to the Terms & Conditions.  Text Message frequency may vary.  Message & Data rates may apply.  You may opt-out of SMS at any time by replying STOP to the phone number we texted you from.  Reply HELP for help to the phone number we texted you from..  You may view our Privacy Policy here.

We are here to listen and help. 
Submit below to speak with our team.

 Ronnie Roman Sexual Abuse Claim Help

Blood Cancers Linked to Roundup

Information submitted will be transmitted to a law firm. This communication is intended to be an attorney-client communication for purposes of evaluating your claim and will be kept confidential by the law firm. The communication does not create an attorney-client relationship and no relationship is formed until a fee agreement is signed by you and the law firm. I also have read and agree to your Privacy Policy

File Your Claim Now

April 2022: The MDL Paraquat class action judge will have a status conference on April 1st to review where the litigation is headed and how best to take the bellwether lawsuits forward for trial in November 2022. 44 new paraquat lawsuits have been added to the MDL in the last two weeks. At this pace, April 2022 will be the busiest month for new files yet. Last week, the parties filed their class-action bellwether picks with the Paraquat MDL judge. Those choices, however, have not been made public.

May 2022: In the last month, over 50 new cases have been added to the Paraquat Lawsuit Multidistrict Litigation (MDL). A group of six patients was recently selected by the Paraquat MDL court for the initial Paraquat Parkinson's disease bellwether trials. As a result, the first trial in November 2022 is approaching soon. The strategy is to select 16 paraquat claims from among the almost 1000 Parkinson's disease litigation claims filed. Following some limited fact discovery in these instances, paraquat attorneys on both sides submitted a preference list to the MDL court, ranking the 16 cases in order of priority. Attorneys for plaintiffs seek the finest facts for their clients, while defense attorneys want the worst. The judge whittled the list down to six Paraquat claims based on these rankings.

CLAIM UPDATES 

We are here to listen and help answer all your questions. Contact us today for a Free Claim Review by filling out the form above.

Roundup Developments

Anyone who was diagnosed with cancer after Roundup exposure should contact us now. Seek the justice and closure you deserve. 

Significant compensation may be available. Free Claim Review.

Seek Justice Today

Maryland Juvenile Detention 

Abuse Claim Help

Jeff Brandow

Sexual Abuse

Claim Help

File Your Claim Now

Anyone who has used Monsanto’s Roundup and has been diagnosed with Non Hodgkin's Lymphoma or one of it's many subtypes, may be eligible to file a claim. In 2020, Bayer, the parent company of Monsanto, reached an $11 billion settlement to cover all existing and future cases against the weed killer's links to cancer. However, in 2023, juries have awarded over $2 billion in damages that were not covered by the initial settlement, prompting Bayer to set aside an additional $6 billion to cover pending and potential future lawsuits. If you or someone you love were diagnosed with cancer after Roundup exposure, contact us today for a Free Claim Review. Seek the justice and compensation you deserve.

"Trust our experienced team to handle your claim with care and commitment. Contact us today for reliable legal support."

How to Qualify for a Depo-Provera Claim:
Use of Depo-Provera
Diagnosis of Brain Tumor
Document Evidence
Submit The Form Above

Depo-Provera is an injectable birth control containing the synthetic hormone medroxyprogesterone acetate, is linked to an increased risk of meningioma, a rare brain tumor. This risk was not adequately disclosed to consumers or medical professionals. Studies, including those published in the Journal of the American Medical Association (JAMA), have shown that long-term use of Depo-Provera significantly raises the risk of developing meningiomas. 

Claims against Pfizer, Inc., the drug’s manufacturer, alleges that the company knew or should have known about the increased risk of meningiomas—brain tumors that can cause severe neurological symptoms—especially with prolonged use. The claims state that Pfizer failed to adequately warn doctors and patients, rushed the drug to market without sufficient long-term studies, and prioritized profits over safety.

Due to the rising number of claims against Pfizer regarding Depo-Provera and brain tumors have been consolidated into multidistrict litigation (MDL) in federal court. Affected individuals may seek compensation for medical expenses, long-term care, and other damages, with the potential for federal court consolidation of cases.

NHL Cancer Claims

Justice & Compensation Help

Easily File a Claim for...

Non-Hodgkin's Lymphoma (NHL)
B-Cell Lymphomas
T-cell Lymphomas
Follicular Lymphoma (FL)
Mantle Cell Lymphoma (MCL)
Burkitt Lymphoma
Chronic Lymphocytic Leukemia(CLL/SLL)
Hairy Cell Leukemia (HCL)
Primary Central Nervous System (CNS) Lymphoma
Lymphoplasmacytic Lymphoma (LPL)

Angioimmunoblastic T-Cell Lymphoma (AITL)
 

Multiple Myeloma
Anaplastic Large Cell Lymphoma (ALCL)
Breast Implant-associated ALCL
Extranodal NK/T-Cell Lymphoma, Nasal Type
Enteropathy-Associated T-Cell Lymphoma (EATL)
Hepatosplenic T-Cell Lymphoma
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Mucosa-Associated Lymphoid Tissue Lymphoma (MALT Lymphoma)
Waldenstrom Macroglobulinemia (WM)

Death of a Loved One

Several studies have found evidence linking the weed killer’s main ingredient, glyphosate, to serious side effects and certain types of cancer, including Non Hodgkin's Lymphoma and it's various subtypes.

The World Health Organization’s International Agency for Research on Cancer (IARC) recently found that glyphosate in Roundup is likely a cancer-causing agent. The IARC report linked the side effects of Roundup to an increased risk of Lymphoma and Leukemia. A 2023 study identified a heightened NHL risk from glyphosate-based herbicides, including hairy cell leukemia.

Most recently in October 2024, a jury awarded William and Margaret Melissen $78 million. William was diagnosed with a form of non-Hodgkin's lymphoma after nearly 30 years of Roundup use also in Philadelphia.

January 2024: John McKivison, a gardener in Pennsylvania, was awarded $400 Million, after he was diagnosed with Non-Hodgkin’s Lymphoma. 

A San Diego jury granted Mike Dennis from Carlsbad, CA, $332 million on October 31, 2023. Dennis argued that his extensive use of Roundup over many years led to his Non-Hodgkin's Lymphoma. The award comprised $7 million for compensatory damages and $325 million for punitive damages. 

In August 2018, a jury for the Superior Court of California ordered Monsanto to pay $289 million to Dewayne Johnson, a former school district groundskeeper, because of Roundup’s likely role in contributing to his cancer.  As a result, the number of glyphosate lawsuits against Monsanto has increased to more than 8,700 cases.

Significant Settlements

QUALIFY IN MINUTES